Group in Economics and Health, Universidade Federal de Minas Gerais (UFMG), Belo Horizonte (MG), Brazil.
Department of Statistics, Universidade Federal de Minas Gerais (UFMG), Belo Horizonte (MG), Brazil.
Qual Life Res. 2021 Jun;30(6):1595-1604. doi: 10.1007/s11136-020-02734-9. Epub 2021 Jan 16.
Despite the advancements in renal replacement therapy, patients with end-stage renal disease face several limitations, with significant impacts on health-related quality of life (HRQoL) and mortality. This study aims to examine associations between quality of life and risk of death in Brazilian patients who underwent dialysis therapy between 2007 and 2015.
Observational, prospective, non-concurrent cohort study of patients who underwent dialysis therapy at the Brazilian Public Health System (SUS) and were followed up for 8 years. Semi-structured questionnaires interrogating socioeconomic and demographic characteristics, as well as HRQoL measures (36 Item Short-Form Health Survey, SF-36), were employed. The Cox proportional risk model was used to investigate associations between HRQoL and risk of death.
Our sample comprised 1162 patients; of these, 884 were on hemodialysis (HD) and 278 on peritoneal dialysis (PD). Among the HD patients, death was associated with the physical (HR: 0.993; 95% CI: 0.989-0.997) and physical summary component (HR: 0.994; 95% CI: 0.989-0.999) domains of HRQoL. Regarding the PD patients, death was associated with the bodily pain (HR: 0.994; 95% CI: 0.990-0.998), mental health (HR: 0.094; 95% CI: 0.990-0.998), emotional problems (HR: 0.993; 95% CI: 0.987-0.998), social functioning (HR: 1.012; 95% CI: 1.002-1.023), physical problems (HR: 0.992; 95% CI: 0.986-0.998) and mental summary component (HR: 0.989; 95% CI: 0.981-0.997) domains of HRQoL.
Our data suggest that early and timely intervention measures aiming to enhance the HRQoL of dialysis patients are an essential component of professional practice and may contribute to improving the management of factors associated with dialysis patients' mortality.
尽管肾脏替代疗法取得了进步,但终末期肾病患者仍面临多种限制,对健康相关生活质量(HRQoL)和死亡率有重大影响。本研究旨在探讨 2007 年至 2015 年间在巴西接受透析治疗的患者生活质量与死亡风险之间的关系。
这是一项对在巴西公共卫生系统(SUS)接受透析治疗并接受 8 年随访的患者进行观察性、前瞻性、非同期队列研究。使用半结构式问卷询问社会经济和人口统计学特征以及 HRQoL 测量(36 项简短健康调查,SF-36)。使用 Cox 比例风险模型探讨 HRQoL 与死亡风险之间的关系。
我们的样本包括 1162 名患者;其中 884 名患者接受血液透析(HD),278 名患者接受腹膜透析(PD)。在 HD 患者中,死亡与 HRQoL 的身体(HR:0.993;95%CI:0.989-0.997)和身体综合评分(HR:0.994;95%CI:0.989-0.999)领域相关。对于 PD 患者,死亡与身体疼痛(HR:0.994;95%CI:0.990-0.998)、心理健康(HR:0.094;95%CI:0.990-0.998)、情绪问题(HR:0.993;95%CI:0.987-0.998)、社会功能(HR:1.012;95%CI:1.002-1.023)、身体问题(HR:0.992;95%CI:0.986-0.998)和心理健康综合评分(HR:0.989;95%CI:0.981-0.997)相关。
我们的数据表明,旨在提高透析患者 HRQoL 的早期和及时干预措施是专业实践的重要组成部分,可能有助于改善与透析患者死亡率相关因素的管理。